Concepts (330)
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Melody Cobleigh's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Melody Cobleigh has written about over time.
Antibodies, MonoclonalAntineoplastic AgentsMiddle AgedHumansNeoplasm MetastasisFemaleAntibodies, Monoclonal, HumanizedBreast NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsMastectomy, SegmentalBiomarkers, TumorTrastuzumabReceptor, ErbB-2Protein Kinase InhibitorsCarcinoma, Intraductal, NoninfiltratingClass Ia Phosphatidylinositol 3-KinaseBreast Neoplasms, MaleDrug Resistance, NeoplasmAntineoplastic Agents, ImmunologicalSTAT6 Transcription Factor
To see the data from this visualization as text,
click here.
Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
Antibodies, Monoclonal | 14 | 1999 | 2011 | August 2004 |
Antineoplastic Agents | 20 | 1982 | 2019 | October 2004 |
Middle Aged | 44 | 1983 | 2021 | July 2005 |
Humans | 78 | 1981 | 2022 | July 2005 |
Neoplasm Metastasis | 19 | 1981 | 2019 | April 2006 |
Female | 72 | 1981 | 2022 | May 2006 |
Antibodies, Monoclonal, Humanized | 17 | 2001 | 2014 | February 2007 |
Breast Neoplasms | 68 | 1981 | 2022 | October 2007 |
Antineoplastic Combined Chemotherapy Protocols | 20 | 1993 | 2022 | October 2009 |
Mastectomy, Segmental | 3 | 1994 | 2021 | November 2009 |
Biomarkers, Tumor | 9 | 2001 | 2019 | February 2010 |
Trastuzumab | 17 | 2001 | 2021 | April 2011 |
Receptor, ErbB-2 | 19 | 1999 | 2022 | October 2012 |
Protein Kinase Inhibitors | 2 | 2008 | 2019 | December 2013 |
Carcinoma, Intraductal, Noninfiltrating | 2 | 2013 | 2021 | July 2017 |
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2019 | 2019 | June 2019 |
Breast Neoplasms, Male | 1 | 2019 | 2019 | November 2019 |
Drug Resistance, Neoplasm | 2 | 2019 | 2020 | December 2019 |
Antineoplastic Agents, Immunological | 2 | 2019 | 2020 | February 2020 |
STAT6 Transcription Factor | 1 | 2020 | 2020 | June 2020 |
To return to the timeline,
click here.